Home / Market Reports / Service & Software / Global AI Drug Target Discovery Service Market Growth (Status and Outlook) 2024-2030

Global AI Drug Target Discovery Service Market Growth (Status and Outlook) 2024-2030

Global AI Drug Target Discovery Service Market Growth (Status and Outlook) 2024-2030

Product Code:1247584

Published Date: Dec 29,2024

Pages: 88

Region: Global

Category: Service & Software

PDF DOWNLOAD

GET FREE SAMPLE

CUSTOMIZE REQUEST

PDF DOWNLOAD

GET FREE SAMPLE

CUSTOMIZE REQUEST

SELECT A FORMAT

ADD TO BASKET

BUY NOW

Provide comprehensive and accurate analysis and reports according to your exact requirements

Provide comprehensive and accurate analysis and reports according to your exact requirements

CONTACT US 

The global AI Drug Target Discovery Service market size is predicted to grow from US$ 3320 million in 2024 to US$ 11990 million in 2030; it is expected to grow at a CAGR of 23.9% from 2024 to 2030.

AI Drug Target Discovery Service refers to a method that uses artificial intelligence technology to identify, validate and screen potential drug targets. By analyzing and mining massive biomedical data, this method uses machine learning, deep learning and other algorithms to predict and identify disease-related biomolecules, which can be used as targets for drug development, thereby accelerating the process of new drug discovery and research and development.

United States market for AI Drug Target Discovery Service is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

China market for AI Drug Target Discovery Service is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Europe market for AI Drug Target Discovery Service is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Global key AI Drug Target Discovery Service players cover XtalPi, Insilico Medicine, Exscientia, Atomwise, Benevolent AI, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2023.

LPI (LP Information)' newest research report, the “AI Drug Target Discovery Service Industry Forecast” looks at past sales and reviews total world AI Drug Target Discovery Service sales in 2023, providing a comprehensive analysis by region and market sector of projected AI Drug Target Discovery Service sales for 2024 through 2030. With AI Drug Target Discovery Service sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world AI Drug Target Discovery Service industry.

This Insight Report provides a comprehensive analysis of the global AI Drug Target Discovery Service landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on AI Drug Target Discovery Service portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global AI Drug Target Discovery Service market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for AI Drug Target Discovery Service and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global AI Drug Target Discovery Service.

This report presents a comprehensive overview, market shares, and growth opportunities of AI Drug Target Discovery Service market by product type, application, key players and key regions and countries.

Segmentation by Type:
    Protein Discovery
    Enzyme Discovery
    Receptor Discovery

Segmentation by Application:
    Pharmaceutical Company
    CRO and Universities
    Others

This report also splits the market by region:
    Americas
        United States
        Canada
        Mexico
        Brazil
    APAC
        China
        Japan
        Korea
        Southeast Asia
        India
        Australia
    Europe
        Germany
        France
        UK
        Italy
        Russia
    Middle East & Africa
        Egypt
        South Africa
        Israel
        Turkey
        GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
    XtalPi
    Insilico Medicine
    Exscientia
    Atomwise
    Benevolent AI
    Insitro
    Xaira Therapeutics
    Tempus AI
    AbCellera